Dr. Alvaro Jose Dominguez, MD

Dr. Dominguez practices at Cardiovascular Consultant of New York in New York, New York.

Dr. Dominguez's NPI, 1891806881, was assigned on August 31, 2006. Dr. Dominguez holds New York license 175733.

Dr. Dominguez's primary practice is Cardiovascular Consultant of New York, at 715 W 170th St, New York, NY 10032 in New York County. The practice phone is (212) 781-3722.

Dr. Dominguez's primary practice is Cardiovascular Consultant of New York in New York, New York. Dr. Dominguez is also affiliated with Lenox Hill Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Dominguez to 2 more medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dominguez practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Dominguez's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Dominguez is licensed in New York.

CMS data shows 995 Medicare services from Dr. Dominguez across 14 procedure codes in 2024, for 137 Medicare patients. Medicare paid $92,377 for them.

CMS counts 137 Medicare patients who saw Dr. Dominguez in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dominguez's median patient age at 68, with 59% women.

In 2024, Dr. Dominguez wrote 11,962 Medicare Part D claims for 957 patients. 91% of them were for generic drugs. CMS names the drug for 11,666 of them, across 73 drugs with 11 or more claims each, at $848,875 in total drug cost. In 2023, CMS named 10,375 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Dominguez for performance year 2024, reported through an alternative payment model (APM). Dr. Dominguez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dominguez as offering telehealth. CMS counts 16 procedures of coronary angioplasty and stenting by Dr. Dominguez, more than 42% of the clinicians it reports for that procedure.

CMS Open Payments shows 96 general payments to Dr. Dominguez from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $660.